A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer

Oren Levy, W. Nathaniel Brennen, Edward Han, David Marc Rosen, Juliet Musabeyezu, Helia Safaee, Sudhir Ranganath, Jessica Ngai, Martina Heinelt, Yuka Milton, Hao Wang, Sachin H. Bhagchandani, Nitin Joshi, Neil Bhowmick, Samuel R. Denmeade, John T. Isaacs, Jeffrey M. Karp

Research output: Contribution to journalArticle

Abstract

Despite considerable advances in prostate cancer research, there is a major need for a systemic delivery platform that efficiently targets anti-cancer drugs to sites of disseminated prostate cancer while minimizing host toxicity. In this proof-of-principle study, human mesenchymal stem cells (MSCs) were loaded with poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) that encapsulate the macromolecule G114, a thapsigargin-based prostate specific antigen (PSA)-activated prodrug. G114-particles (~950 nm in size) were internalized by MSCs, followed by the release of G114 as an intact prodrug from loaded cells. Moreover, G114 released from G114 MP-loaded MSCs selectively induced death of the PSA-secreting PCa cell line, LNCaP. Finally, G114 MP-loaded MSCs inhibited tumor growth when used in proof-of-concept co-inoculation studies with CWR22 PCa xenografts, suggesting that cell-based delivery of G114 did not compromise the potency of this pro-drug in-vitro or in-vivo. This study demonstrates a potentially promising approach to assemble a cell-based drug delivery platform, which inhibits cancer growth in-vivo without the need of genetic engineering. We envision that upon achieving efficient homing of systemically infused MSCs to cancer sites, this MSC-based platform may be developed into an effective, systemic 'Trojan Horse' therapy for targeted delivery of therapeutic agents to sites of metastatic PCa.

Original languageEnglish (US)
Pages (from-to)140-150
Number of pages11
JournalBiomaterials
Volume91
DOIs
StatePublished - Jun 1 2016

Keywords

  • Cell-based drug delivery
  • Prostate cancer
  • Stem cells

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    Levy, O., Brennen, W. N., Han, E., Rosen, D. M., Musabeyezu, J., Safaee, H., Ranganath, S., Ngai, J., Heinelt, M., Milton, Y., Wang, H., Bhagchandani, S. H., Joshi, N., Bhowmick, N., Denmeade, S. R., Isaacs, J. T., & Karp, J. M. (2016). A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer. Biomaterials, 91, 140-150. https://doi.org/10.1016/j.biomaterials.2016.03.023